Jacqueline Anastassiades has been involved in the development of the Cypriot healthcare sector for more than 10 years as the Managing Director of MSD. With the upcoming healthcare reforms, she brings her expert insights into the key requirements the Cyprus national health system should validate as well as the significant role of MSD in Cyprus in providing life-changing treatments to patients, ensuring their availability and supporting the local community through CSR activities.
Globally, MSD ranks fourth in terms of pharmaceutical sales. How important is MSD for the Cyprus environment?
"We believe it is our responsibility to address the health needs of patients and the society we live through transformational science by delivering vaccines, medicines that can help patients in Cyprus."
